Chromatin diminution, also termed programmed DNA elimination, removes chromosomal material during early development. In metazoans, this generally involves the loss of chromosomal fragments, predominantly heterochromatin, from cells of the somatic lineage. In protozoa, the process can remove entire chromosomes or sequences interspersed among genic loci.

The phenomenon is species-specific, and the diploid chromosome number after diminution may remain unchanged or change. Theodor Boveri first described chromatin diminution in 1887, and the review describes a research history extending for more than a century. During the fourth embryonic cleavage division, 94% of nuclear DNA is excised from the chromosomes of somatic-line cells, while germline cells retain their genome unchanged throughout development.

The diploid chromosome number remains unchanged, and the review states that the remaining 6% is sufficient for normal adult functions. Because this large fraction can be removed without disrupting somatic ontogeny, the authors treat the eliminated DNA as non-coding for the somatic lineage. The review positions C. kolensis as a model for investigating the C-value enigma: the large differences in genome size that do not correspond directly to differences in gene number or biological complexity.

Eukaryotic genome sizes can vary by more than 200,000-fold, while much of the excess DNA is non-coding. Proposed explanations have included selective neutrality, regulatory and structural functions, mutational pressure from insertions and deletions, and the possibility that genome-size changes are themselves subject to natural selection. The review presents C. kolensis as an experimental system for testing what happens when nearly all non-coding material is removed from a developing somatic genome.

Molecular analyses indicate that the eliminated material is not structurally simple. The review describes repeated sequences, spacers, mosaic fragments and direct and inverted repeats that are often highly similar or identical to consensus sequences. One eliminated repeat showed 97–98% sequence homology between Moscow and Baikal populations, with closely matching sequences retained in somatic cells.

The authors argue that this conservation is difficult to reconcile with a purely “junk” classification. They hypothesize that some eliminated sequences may have germline functions, including roles in meiosis or germ-cell maturation, but the review does not establish those functions directly. Chromatin diminution in C. kolensis is also associated with a lasting change in interphase-nuclear architecture.

Before diminution, embryonic cells have relatively homogeneous, diffuse nuclei. After the process, condensed heterochromatic segments and chromocenters become detectable, including chromocenters adjacent to the nuclear membrane, giving the nuclei an appearance resembling that of differentiated cells. The review interprets this transition as coinciding with the maternal-to-zygotic transition and as evidence that diminution may participate in the regulation of differentiation between somatic and germ lineages.

Timing experiments provide additional evidence for nuclear control of the process. In a cited irradiation experiment, high radiation doses that impaired nuclear-genome function stopped chromatin diminution. The authors infer that the mechanisms regulating the morphogenetic function of C. kolensis nuclei are triggered during the fourth cleavage division, when chromatin reduction occurs.

This finding supports initiation through zygotic nuclear activity, although the review does not identify the individual regulatory factors or establish the full molecular pathway. Experiments in C. kolensis also found that chromosome-aberration frequencies were 30–50 times lower after diminution than before it. That change was larger than the roughly 15- to 16-fold reduction predicted if aberration frequency simply scaled with the amount of remaining DNA.

The review discusses a model in which aberrations arise disproportionately in DNA associated with nuclear-matrix attachment regions and diminution removes a disproportionate share of those regions. The proposed reduction in DNA–matrix contact points remains an assumption in this explanatory model rather than a directly demonstrated result. The review also considers how non-coding DNA might influence recombination and genome evolution.

One hypothesis proposes that non-coding sequences separate genes, exons, introns, regulatory elements and structural features, thereby increasing opportunities for recombination and generating a wider range of sequence variants. Under this model, genome reduction after adaptation to a narrow ecological niche could limit further exploration of sequence space. A separate evolutionary model places chromatin diminution within incomplete genome reduction: somatic cells shed DNA that is unnecessary for later development, whereas germline cells retain sequences needed for meiosis and early embryogenesis.

Possible reproductive isolation is also examined. Russian and German C. kolensis populations differ in the timing of diminution and in the distribution of eliminated chromatin during anaphase, while German Cyclops insignis reportedly undergo diminution whereas Russian populations do not. Models combining genome reduction, altered chromosome order and hybrid meiosis propose a route to reproductive barriers.

These scenarios are hypothetical, and the review does not demonstrate that chromatin diminution caused speciation.

Subject of Research: Review of programmed DNA elimination, genome reduction and cellular differentiation in animals

Article Title: Chromatin diminution as a tool to study some biological problems

Article References: Grishanin, A. (2024). Chromatin diminution as a tool to study some biological problems. Comparative Cytogenetics, 18, 27-49. https://doi.org/10.3897/compcytogen.17.112152

Image Credits: AI Generated

DOI: 10.3897/compcytogen.17.112152

Keywords: chromatin diminution, programmed DNA elimination, genome reduction, non-coding DNA, copepods, Cyclops kolensis, nuclear architecture, cell differentiation, genetic isolation, C-value enigma, Chromatin, diminution

Wheat reorganized its gene regulation during this interval, and selected genes acquired histone-modification signatures before the next cold event arrived. The results suggest that cold memory is associated with photosystem adaptation and a distinctive post-stress regulatory program. The experiment used wheat seedlings in a three-stage sequence.

Researchers from Nanjing Agricultural University first exposed the seedlings to a non-lethal cold treatment, allowed them to recover fully after temperatures returned to normal, and then subjected them to an even stronger chill. Other plants had no prior cold exposure when they encountered the stronger treatment. This sequence made it possible to compare the later response of primed plants with that of previously unexposed plants while also tracking what happened during recovery.

The study was an experimental investigation of a defined plant system, so the findings concern the tested wheat seedlings and conditions rather than a direct demonstration of improved field performance or crop yield. One of the clearest results was that the effect of the first cold exposure did not disappear when the cold treatment ended. Some differences between primed and unprimed plants persisted after recovery, showing that the later response was not simply the result of stress-response genes remaining continuously switched on.

Instead, many genes responded with a delay. Genes involved in jasmonic acid biosynthesis, heat-shock responses, protein folding, and other protective processes were only weakly activated immediately after the initial cold treatment but became much more active after temperatures had returned to normal. The delayed pattern indicated that recovery itself was associated with a distinct phase of regulation in which wheat reorganized its response after the original stress had disappeared.

Molecular analysis linked this delayed response to lasting changes in histone modifications at selected genes. The researchers found that some stress-responsive genes gained H3K4me3, a mark generally associated with active transcription, while others lost H3K27me3, a mark commonly linked to repression. In several cases, the modification changes appeared before large differences in gene expression became evident.

Their timing supports the interpretation that the initial cold exposure left a molecular record at selected genes, preserving information from the earlier stress without requiring the plant to maintain a broad, continuously elevated stress response. The study associates these chromatin changes with cold memory, but it does not establish the complete molecular pathway responsible for the phenomenon. The physiological measurements showed that the molecular changes coincided with measurable differences during the later chill.

Primed plants displayed better photosystem II performance, less hydrogen peroxide accumulation, and higher levels of key antioxidants than plants without the initial cold exposure. These results indicate that prior mild chilling was associated with greater tolerance under the subsequent, stronger treatment. They also provide a functional counterpart to the delayed gene responses and histone-modification signatures observed during recovery.

The researchers did not report field trials, agricultural outcomes, or the effect of priming on wheat yield in the supplied description of the study, so those broader applications cannot be inferred from the experimental result. Signs of the altered molecular state were already present before the second cold event. Many photosystem-related genes had acquired different histone-modification states while their transcript levels remained largely unchanged.

In other words, the change in regulatory condition preceded a major shift in gene expression. Instead, they entered the new stress with selected genes already marked by the earlier exposure. The timing is central to the study because it places preparation for renewed cold within the recovery period, when the first stress had ended but its molecular consequences remained detectable.

The photosynthetic response produced the study’s most unexpected feature. Strong activation of genes associated with photosystem components and chloroplast protein synthesis could have indicated that primed plants mounted a more intensive repair response during the second chill. Instead, plants without prior exposure strongly induced many of these genes, whereas primed plants showed weaker induction despite retaining photosystem II in better condition.

The researchers described this as primed plants appearing to need less repair. Their advantage was therefore not a larger repair-and-replacement response. It was the better preservation of photosynthetic function during renewed cold, accompanied by a smaller requirement for the extensive response seen in previously unexposed plants.

The observed gene-expression pattern was consistent with the idea that plants suffering less photosynthetic damage have less need to replace damaged components or increase chloroplast protein synthesis. The researchers did not claim that primed plants lacked repair capacity; the evidence instead concerns how strongly repair-related genes were induced under the tested conditions. Their findings support enhanced photosystem tolerance, rather than intensive repair capacity alone, as an important feature of cold memory.

Because the experiments involved seedlings and controlled cold treatments, the study also does not show that the same response is equally effective across other wheat varieties, growth environments, or field conditions. Taken together, the experiments place the post-stress recovery phase at the center of a broader model of cold memory in wheat. Mild priming altered physiological performance during later chilling, while the recovery interval was marked by delayed protective gene responses and selective histone-modification changes.

Many of those changes were visible before renewed cold arrived. At the same time, better photosystem II condition was accompanied by weaker induction of many repair- and replacement-related genes than occurred in previously unexposed plants. The study does not establish how long the memory persists, whether priming can be used to improve agricultural performance, or exactly how chloroplast-derived signals interact with chromatin-regulating mechanisms in the nucleus.

The authors identified that final question as an area for further work, while the present results show that recovery after cold is an active biological window in which wheat reorganizes its response to a subsequent chill.

Subject of Research: Experimental investigation of cold priming, gene regulation, histone modifications, and photosystem adaptation in wheat seedlings.

Article Title: Wheat remembers the cold: Molecular changes prepare plants for the next chill

Article References: Wheat remembers the cold: Molecular changes prepare plants for the next chill. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: wheat, cold priming, stress memory, photosystem II, histone modifications, gene regulation, chromatin, photosynthesis, antioxidants, crop resilience, remembers, cold

DNA repair requires proteins both to carry out repairs and to recognize molecular signals associated with when and where repair is needed. Dr. Jean-François Couture, a full professor in the University of Ottawa Faculty of Medicine’s Department of Biochemistry, Microbiology and Immunology and the study’s co-corresponding author, said the work shows how changes that interfere with this recognition can compromise repair, threaten genome stability and ultimately contribute to disease. TONSL, a protein involved in maintaining genome integrity, emerged from the study as a central coordinator in this process.

The researchers found that TONSL interacts with H3.1 through several molecular binding pockets rather than through a single point of contact. Two pockets recognized specific modifications on the histone: methylation at one position and acetylation at another. These chemical marks are associated with DNA regions involved in regulating genes. Their results therefore indicate that DNA-repair recognition depends partly on the modification state of surrounding chromatin, including histone variants that can carry distinct molecular features recognized by other proteins. The binding pockets collectively allowed TONSL to interpret multiple signals associated with H3.1.

Human-cell experiments provided a disease-related test of this recognition mechanism. Mutations in a region of TONSL associated with sponastrime dysplasia weakened the protein’s ability to recognize H3.1, and the altered proteins failed to restore normal DNA repair function. Couture described this as evidence that the mutations disrupt the ability to coordinate repair machinery as cells prepare for division, allowing DNA damage to accumulate. The findings support a possible contribution of defective TONSL recognition to sponastrime dysplasia; they do not establish that the entire spectrum of the inherited skeletal disorder can be explained by this molecular defect.

The study builds on the team’s earlier work published in Science in 2022. Since then, new collaborations enabled the researchers to extend their analysis from isolated proteins to interactions involving living human and mammalian cells, providing a broader view of how TONSL and H3.1 behave in cellular systems. Dr. Hossein Davarinejad, the first author and a postdoctoral fellow in Couture’s laboratory, said the team next plans to investigate other proteins involved in DNA repair pathways and conduct structural studies of larger parts of the repair machinery. Overall, the experiments show that protecting genetic information involves more than executing repair: the repair system must also interpret the chemical features of chromatin to coordinate the response appropriately.

Subject of Research: Molecular recognition of histone H3.1 modifications by TONSL in DNA repair and genome stability

Article Title: Unravelling DNA repair: uOttawa-led team shows how cells protect their genetic blueprint

Article References: Unravelling DNA repair: uOttawa-led team shows how cells protect their genetic blueprint. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: TONSL, DNA repair, histone H3.1, genome stability, chromatin, protein recognition, sponastrime dysplasia, cell division, University of Ottawa, Unravelling, repair, uOttawa-led

Chromatin diminution is a specialized developmental process in which a portion of the DNA is removed from the chromosomes of embryonic somatic-line cells. In C. kolensis , a zooplanktonic crustacean in the order Cyclopoida, the process occurs during the fourth cleavage division. Before this point, embryonic presomatic cells contain the same genome as the future germ line.

During diminution, somatic-line nuclei lose roughly 90% of their DNA, whereas germ-line cells retain their nuclear DNA unchanged throughout development. The study describes chromatin diminution as a marker of germline-soma differentiation and notes that the interphase before the diminution division is unusually long. The investigators designed the experiment to test whether nuclear activity is required to initiate chromatin diminution.

They reasoned that radiation could separate the effects of cytoplasmic determinants from the contributions of embryonic genes. Doses in the range used for nuclear inactivation were expected to produce chromosome aberrations while leaving enough cytoplasmic function for cleavage and other early developmental processes to continue. If nuclei were essential for launching diminution, extensive radiation damage should have prevented the process.

Instead, the observed survival of diminution under high doses supports a prominent role for factors already present in the fertilized egg’s cytoplasm. For the main irradiation experiments, the researchers used C. kolensis embryos at the four-cell stage, although some embryos at the two-cell stage received the highest dose. Irradiation was performed with gamma radiation at the Rokus-M facility of the Joint Institute for Nuclear Research.

Absorbed doses ranged from 5 to 200 Gy, delivered at a dose rate of 1.37 Gy per minute from a distance of 0.75 m. Embryos were examined 24 hours later. A mixture of ethanol and acetic acid was used for one hour of fixation, and aceto-orcein staining prepared the specimens for light microscopy.

The researchers counted blastomeres, inspected chromosome behavior during division and assessed micronuclei as indicators of chromosomal abnormalities. Data were processed using a t-test. The 5-Gy exposure produced a mixed developmental outcome.

Visible granules of eliminated chromatin indicated that diminution had occurred in all embryos irradiated at this dose. In the limited anaphases available for observation, the researchers recorded chromosome bridges, fragments and fused chromosomes. Thus, although this dose caused substantial chromosomal disruption, it did not prevent either the fourth cleavage division or the DNA-removal program that normally occurs during it.

At 20 Gy, approximately 41.0% of 307 embryos completed only one further division and reached the eight-cell stage, while 58.9% stopped at 16 cells after passing through the stage at which diminution normally occurs. Among 80 interphase figures assessed for micronuclei at the eight-cell stage, the mean was 1.14 micronuclei per cell, with a standard error of the mean of 0.35. A 100-Gy dose produced a similar developmental pattern: 64.5% of 353 embryos stopped at eight cells and 35.4% reached 16 cells.

The rare division figures again showed numerous bridges, chromosome fragments and adhering chromosomes. Although development failed, progression through the diminution stage indicated that nuclear damage did not suppress initiation of the process. The most extreme dose, 200 Gy, was administered to embryos at the two-cell stage, limiting direct comparisons with the lower doses that began at the four-cell stage.

Thirty-four percent of the 146 embryos stopped at the two-cell stage, apparently reflecting damage to cytoplasmic as well as nuclear structures. In 14 of 36 embryos, the usual signs of chromatin diminution were absent: researchers observed neither the expected abundance of eliminated-chromatin granules nor the sharp size difference between somatic-line cells before and after diminution. At this dose, chromosomes formed conglomerates that could not segregate normally during division.

Micronuclei were also observed in eight-cell embryos, and their mean number rose as radiation dose increased from 20 to 200 Gy. Across the 20–200-Gy treatments, irradiated embryos did not develop beyond the 16-cell stage, with some arresting earlier. The authors interpreted this pattern as evidence that early progression and the initiation of chromatin diminution are governed by a developmental program encoded in cytoplasmic determinants of the egg.

When nuclear function was lost, the embryo could nevertheless execute diminution before ceasing development. The comparison does not establish that nuclei are irrelevant to later morphogenesis: the numerous chromosomal aberrations could have blocked nuclear functions required for continued development. Rather, the results separate the apparently cytoplasm-driven initiation of diminution from the nuclear functions needed for subsequent embryonic growth.

A comparable phenomenon had previously been reported in the nematode Ascaris suum , whose embryos also undergo chromatin diminution. Irradiation of four-cell A. suum embryos prevented development beyond 16 cells, while radiation blocked the nuclear genome without suppressing chromatin diminution. The present study notes, however, that the earlier Ascaris experiment was not designed specifically to test diminution.

Its purpose was to examine radiation effects on early development. The newer experiment applies nuclear-inactivation logic directly to C. kolensis , adding evidence from a copepod whose diminution occurs specifically during the fourth cleavage division. The study has important measurement limitations.

The researchers did not systematically compare the frequency of chromosome aberrations across radiation doses using either anaphase analysis or micronucleus counts. Micronucleus counts were unavailable at the 16- and 32-cell stages after 20- and 100-Gy treatments because eliminated-chromatin granules obscured the micronuclei. The apparent dose-related increase in micronuclei was therefore described as a tendency rather than a completed quantitative analysis.

The highest dose was also applied at a different starting stage and damaged cytoplasmic components, so the absence of diminution in 14 embryos may reflect disrupted cytoplasmic organization rather than a direct requirement for nuclear function. The findings therefore support cytoplasmic control over initiation of diminution while identifying an extreme exposure in which damage beyond the nucleus can interfere with the process. Taken together, the results support the long-standing idea that early embryonic cytoplasm contains determinants capable of directing specialized developmental programs.

In C. kolensis , irradiation of nuclei did not generally cancel the somatic program that removes most of the genome during the fourth cleavage division, even though chromosomal damage stopped embryos from developing beyond the 16-cell stage. At 200 Gy, however, some embryos failed to show diminution, indicating that the process can also be disrupted when radiation damage extends beyond the nucleus. The experiment did not identify the individual cytoplasmic factors or establish whether they are proteins, RNAs or other molecules.

Its principal contribution is functional: it shows that severe nuclear inactivation alone is insufficient to prevent chromatin diminution in this copepod, while also revealing a high-dose condition in which disruption of cytoplasmic factors may interfere with the process.

Subject of Research: Experimental test of cytoplasmic control over chromatin diminution in the copepod Cyclops kolensis

Article Title: Study of chromatin diminution in Cyclops kolensis ( Copepoda , Crustacea ) by radiobiological methods

Article References: Grishanin, A., & Chinyakova, O. (2021). Study of chromatin diminution in Cyclops kolensis (Copepoda, Crustacea) by radiobiological methods. Comparative Cytogenetics, 15(4), 329-338. https://doi.org/10.3897/compcytogen.v15.i4.64350

Image Credits: AI Generated

DOI: 10.3897/CompCytogen.v15.i4.64350

Keywords: Chromatin diminution, Cyclops kolensis, Copepoda, Gamma radiation, Embryonic development, Genome reduction, Somatic differentiation, Cytoplasmic determinants, Chromosome damage, Radiobiology, chromatin, diminution

The study was co-led by Dr Maria Carolina Florian, a researcher in the Regenerative Medicine program at IDIBELL and ICREA Research Professor, and Dr Paula Petrone, a researcher at BSC-CNS and ISGlobal, a centre supported by the la Caixa Foundation. The work formed a central part of the doctoral thesis of Pablo Iañez, a researcher at ISGlobal, and combined expertise in stem cell biology, aging, image analysis and machine learning. Their starting point was a well-known clinical and biological problem: as the body ages, the hematopoietic system, the network of organs and tissues responsible for producing blood cells, progressively loses its capacity to maintain adequate blood cell production. Measuring this decline at the level of individual stem cells is essential for understanding hematopoietic aging and for testing strategies designed to slow or reverse it.

Chromatin is the material that makes this measurement possible. It consists mainly of DNA wrapped around proteins, and its spatial organization within the nucleus regulates gene activity, ultimately determining cell identity and function. As stem cells age, this organization changes, but the changes are subtle, heterogeneous and often invisible to a trained observer looking through a microscope. That is precisely where the new model excels. ChromAgeNet is a convolutional neural network, a class of artificial intelligence model designed to analyze images, and it was trained to distinguish young from aged hematopoietic stem cells based solely on the appearance of the nucleus.

To build and train the model, the researchers used three-dimensional microscopy images of mouse hematopoietic stem cell nuclei stained with DAPI, a simple, inexpensive and widely used fluorescent dye that binds to DNA and reveals the distribution of chromatin density inside the nucleus. The choice of DAPI is significant for practical reasons. Because it is a low-cost stain that can be incorporated easily into existing microscopy protocols, the approach does not require exotic reagents or specialized sample preparation, which makes it realistic to deploy in high-throughput microscopy workflows where thousands or millions of samples must be processed automatically.

The performance results are striking. Based on the appearance of the nucleus alone, ChromAgeNet demonstrated a 77 percent probability of correctly sorting cells into two groups, young versus aged. Remarkably, this exceeded the performance of a machine learning model built on chromatin features that the researchers themselves had previously defined by hand. In other words, the deep learning system extracted predictive information from the images that went beyond the features human experts had considered informative. This is a recurring theme in modern image-based biology: neural networks can detect combinations of visual cues that no single engineered feature captures, and here those cues turned out to encode biological age.

One of the most important aspects of the work is that the aging-associated differences are not necessarily visible to the naked eye in the microscopic images. Stem cell aging is a heterogeneous process, meaning that different cells age in different ways and to different degrees, and changes in nuclear architecture can be extremely subtle. ChromAgeNet nevertheless manages to identify combinations of spatial chromatin features that carry information about the aging state of individual cells. This transforms a subjective, qualitative impression of an aged nucleus into a quantitative, scalable measurement that can be applied consistently across large cell populations.

Crucially, the team did not stop at classification. They analyzed the model’s behaviour to determine which specific features of the images were most helpful in distinguishing young cells from aged cells. This interpretability analysis identified several predictive features of the age-associated state, including chromatin entropy, a measure of the disorder or variability in chromatin organization; heterochromatin, the densely packed and generally gene-poor form of chromatin, located at the periphery of the nucleus; and certain chromatin condensates, compact clusters of the DNA-protein complex. Knowing which elements of DNA organization the model relies on allows researchers to go beyond a simple young-versus-old label and gain mechanistic insight into the nuclear architecture of aging.

This mechanistic dimension positions ChromAgeNet as a complement to existing biological age biomarkers rather than a replacement for them. The best known of these are the so-called epigenetic clocks, which estimate biological age from chemical modifications to DNA, particularly methylation patterns. Epigenetic clocks require sequencing-based measurements, whereas ChromAgeNet requires only a stained image, so the two approaches interrogate different layers of the aging process. Combining image-derived chromatin architecture with molecular biomarkers could yield a richer, multi-dimensional picture of how a given stem cell is aging and how it responds to experimental interventions.

The most forward-looking application explored in the study is screening for rejuvenation strategies. As a proof of concept, the researchers applied ChromAgeNet to aged hematopoietic stem cells that had been treated with different epigenetic drugs, asking whether the treatments produced changes in chromatin organization compatible with a younger nuclear state. The authors are careful about what this does and does not show. The results do not demonstrate that the treatments functionally rejuvenated the cells, but they do establish the potential of ChromAgeNet as a tool to detect age-associated chromatin changes in response to interventions. That distinction matters: a model that can flag candidate compounds for closer functional testing accelerates discovery without overclaiming therapeutic effect.

The combination of cheap staining, a small number of model parameters and compatibility with high-throughput microscopy makes the platform unusually scalable. In principle, the same pipeline could be used to study large libraries of compounds, rapidly identifying those that shift the nuclear architecture of aged stem cells toward a younger configuration, which would then be prioritized for deeper functional assays. To support exactly this kind of community-driven development, the researchers have released a dataset of three-dimensional images of hematopoietic stem cells together with ChromAgeNet itself. This is a meaningful contribution in its own right, because publicly available imaging datasets for hematopoietic stem cell aging are currently scarce, and shared benchmarks are what allow computational tools to be validated and improved across laboratories.

Taken together, the study demonstrates that the three-dimensional organization of DNA contains quantifiable information about the aging of blood stem cells, and that artificial intelligence can extract that information from routine microscopic images. ChromAgeNet provides a new, faster and more scalable way to study cellular aging and to explore strategies for preserving or recovering hematopoietic stem cell function. If the approach generalizes beyond mouse cells and finds adoption in screening pipelines, the humble DAPI-stained nucleus, an image type generated in cytometry and microscopy labs every day, may become one of the most informative and inexpensive windows into the biological age of the cells that keep our blood, and ultimately our bodies, running.

Subject of Research: Deep learning detection of hematopoietic stem cell aging from 3D chromatin architecture in nuclear images

Article Title: AI detects signs of aging in blood stem cells from nuclear images

Article References: AI detects signs of aging in blood stem cells from nuclear images. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: artificial intelligence, chromatin, hematopoietic stem cells, aging, DAPI staining, convolutional neural network, nuclear architecture, epigenetic drugs, rejuvenation, Aging Cell, biomarkers, high-throughput microscopy

The stakes of this research are enormous. Genome organization is intimately connected to essential cellular functions such as gene expression, DNA replication, and DNA repair. Enhancers, the distal regulatory elements that boost gene activity, may lie millions of DNA letters away from the genes they control along the linear chromosome, yet they must physically find and contact their targets within the crowded nuclear space. Understanding how the chromatin fiber brings the right pieces together requires more than biology alone; it requires quantitative models in which chromosomes are treated as polymer chains and proteins as interacting particles whose collective behavior can be simulated, perturbed, and compared against experimental data from microscopy and chromosome-conformation assays.

The first pillar of the framework discussed by Fontana and Chiariello is phase separation, the same process that causes oil to bead up in water, here operating on proteins inside the nucleus. Many regulatory proteins carry intrinsically disordered regions that allow them to interact with copies of themselves, forming stable condensates. Well-studied examples include Mediator and RNA polymerase II, which cluster together at active genes, as well as coactivators that assemble at super-enhancers and transcription factors whose activation domains can condense to drive gene expression. At larger scales, phase separation helps build Cajal bodies and the nucleolus, a multi-phase structure assembled from distinct molecular species of proteins and RNA. Crucially, when the phase-separation properties of these proteins go wrong, the result can be disease, ranging from rare genetic disorders involving nucleolar dysfunction to cancer driven by aberrant condensates.

To capture this phenomenon computationally, theorists have built models in which chromatin is represented as a polymer and proteins are represented as particles that bind to it. Some of the simplest versions include only polymer-protein interactions, leaving out direct protein-protein attraction. Even so, these bridging models give rise to what is known as polymer-polymer phase separation, in which the polymer itself nucleates condensates of bound proteins that then glue distant chromatin segments together. Despite their minimalism, such models have successfully reconstructed the three-dimensional structures of real genomic regions, described chromatin remodeling across different cell types, and even tracked how genome architecture is rearranged following viral infections, including SARS-CoV-2.

More realistic systems require explicit protein-protein interactions alongside chromatin-protein affinity, and, in the most complete versions, loop extrusion as well. In loop extrusion, molecular motors of the cohesin or condensin families slide along the chromatin fiber, enlarging DNA loops until they are halted at anchor points, often corresponding to binding sites of the architectural protein CTCF. Single-molecule imaging has now captured this process in real time, and computational studies show that extrusion contributes to global chromosome condensation during mitosis as well as to the local loops and domains that organize the interphase genome. When all these ingredients coexist, the behavior of the system is governed by a set of control parameters, including protein concentration, self-interaction affinity, chromatin affinity, and motor density and processivity, and the resulting equilibrium states fall into complex phase diagrams reminiscent of those studied in condensed matter physics.

One of the most striking predictions to emerge from large-scale molecular dynamics simulations concerns a scenario now called polymer-assisted condensation, or PAC. Simulations revealed that phase-separated condensates can arise in two distinct ways: either spontaneously through strong protein-protein affinity, independently of the polymer, or in a polymer-assisted route in which protein-protein attraction alone is too weak to drive condensation, but binding to chromatin concentrates the proteins enough to tip the system over the threshold. This second mechanism, first predicted computationally and later explored theoretically, has been proposed as a potentially general principle of chromatin organization, with implications for heterochromatin formation and epigenetic memory.

The power of the integrated approach was demonstrated in recent work on PHF13, a protein that binds chromatin enriched with the histone methylation marks H3K4me3 and H3K27me3 and can also self-associate through specific N-terminal sub-domains. Molecular dynamics simulations showed that when both chromatin-protein and protein-protein interactions were enabled at sufficient PHF13 concentration, the modeled polymer collapsed into a compact, roughly spherical globule decorated with PHF13 clusters, mirroring microscopy images of interphase cells overexpressing PHF13, in which chromosomes condense into rounded structures. When the self-interaction domains were disabled in silico, compaction was reduced and condensation disappeared, exactly matching the behavior of engineered PHF13 variants lacking those domains in living cells. The close agreement between simulation and experiment provides a compelling validation of the physics-based framework.

The same modeling philosophy is now being applied to disease. The chimeric protein NUP98-HOXA9, an oncofusion associated with leukemia, can undergo phase separation and bind chromatin, promoting the formation of aberrant loops that bring oncogenes such as PBX3 into contact with distant regulatory elements. Models of the relevant genomic regions accurately recapitulated the aberrant looping patterns observed in experimental Hi-C contact maps from human cells and in single-molecule mobility measurements, while also capturing the interplay between phase separation and loop extrusion that underlies the pathological rewiring. Because altered phase separation has been implicated in cancers and rare genetic diseases, such models offer a route to understanding how molecular-scale misfolding translates into gene misregulation.

The third pillar of the framework concerns the nuclear envelope. The nuclear lamina, a protein network embedded in the inner membrane, adsorbs peripheral chromatin, spatially segregating specific genomic regions from the nuclear interior and repressing their activity. Computational models represent the lamina as an adsorbing membrane that attracts or sterically excludes chromatin segments, with interactions parameterized from DamID profiles that quantify locus-specific lamina association. When loop extrusion and lamina adsorption are combined in a single simulation, the framework accurately reproduces the organization of peripheral loci such as the mouse Sox9 and Kcnj2 region, and tuning chromatin-lamina affinity allows different degrees of peripheral association and distinct cell populations to be described. Simulations of genomic editing, including deletion of CTCF boundary elements, quantitatively matched experimental outcomes, establishing a link between loop extrusion and lamina association even though the two processes act independently.

Fontana and Chiariello conclude that the great advantage of these physics-based models is their versatility: phase separation, loop extrusion, and membrane adsorption can be combined within a single computational framework to describe increasingly detailed biological contexts, at the cost of larger parameter spaces and more complex phase diagrams that molecular dynamics simulations are well suited to explore. Looking forward, the authors point to promising extensions, including modeling pathogenic protein variants, the chromatin changes of ageing, and the architectural disruptions induced by external pathogens such as viruses. As genome-wide datasets grow richer and simulations grow faster, the dream of predicting, and perhaps one day correcting, the physical misfolding events behind human disease moves steadily closer to reality.

Subject of Research: Physics-based computational modeling of chromatin 3D organization through phase separation, loop extrusion, and nuclear lamina adsorption

Article Title: On the physics of chromatin molecular complex: from phase-separation to membrane adsorption

Article References: Fontana, A., & Chiariello, A. M. (2026). On the physics of chromatin molecular complex: from phase-separation to membrane adsorption. Frontiers in Molecular Biosciences, 13, Article 1951961. https://doi.org/10.3389/fmolb.2026.1951961

Image Credits: AI Generated

DOI: 10.3389/fmolb.2026.1951961

Keywords: chromatin, 3D genome organization, phase separation, loop extrusion, polymer physics, nuclear lamina, molecular dynamics, gene regulation, biomolecular condensates, CTCF, cohesin, leukemia

Zygotic genome activation, commonly abbreviated ZGA, is the moment when a newly fertilized egg stops relying on the maternal RNA stockpiled inside the oocyte and begins transcribing its own genes at scale. In mice, this transition culminates during the 2-cell stage, with what researchers call major ZGA occurring in late 2-cell embryos. It is a famously fragile period. A large fraction of embryos cultured in vitro stall at exactly this point, failing to complete the switch from maternal to embryonic control. That developmental arrest is one of the central bottlenecks for assisted reproductive technologies, or ART, and any intervention that eases the passage through ZGA has direct clinical relevance.

The researchers began by comparing mouse embryos cultured under hypoxic conditions with those grown in normal atmospheric oxygen, and with embryos developing in vivo. The results were clear: hypoxic culture improved blastocyst formation and reduced developmental arrest during the ZGA window. When the team profiled gene expression in late 2-cell embryos, they found that the zygotic transcriptome of hypoxia-cultured embryos closely mimicked the patterns seen in physiologically developing, in vivo embryos during major ZGA. In other words, low oxygen did not merely push embryos along; it steered their gene expression toward a more natural trajectory, blunting the artificial signature that in vitro culture typically imprints on the embryonic genome.

To understand how oxygen levels could exert such an influence, the investigators turned their attention to histone modifications, the chemical tags that decorate the protein spools around which DNA is wound. Their focus fell on H3K4me3, the trimethylation of histone H3 at lysine 4, a mark long associated with active and poised promoters. Using CUT&Tag, a sensitive technique for mapping chromatin marks in scarce samples, the team compared H3K4me3 landscapes between hypoxia- and normoxia-cultured late 2-cell embryos. The comparison revealed a striking redistribution. Under hypoxia, H3K4me3 became specifically enriched at the promoters of zygotic genes, while it decreased at transposable elements and at oocyte-specific genomic domains.

That redistribution matters because it tracks precisely with what an embryo needs at this stage. Zygotic genes must be switched on, while the transcription of transposable elements and lingering oocyte programs must be restrained. The elevated H3K4me3 at zygotic promoters under hypoxia was not an isolated observation; the team showed that higher expression deciles of genes corresponded to progressively higher H3K4me3 levels, confirming the expected positive correlation between this mark and transcriptional output. Genes that were upregulated under hypoxia showed enhanced H3K4me3 around their transcription start sites, and genome browser views at representative loci such as Kank2 and Grb2 illustrated the pattern directly.

The mechanistic story deepened when the researchers examined how H3K4me3 related to chromatin accessibility and the machinery of transcription itself. Regions of the genome that were chromatin-accessible, regions enriched for RNA polymerase II, and regions enriched for the Ser2-phosphorylated form of RNA polymerase II, known as Ser2P, all exhibited higher H3K4me3 enrichment in hypoxia-cultured late 2-cell embryos. Ser2 phosphorylation is a critical modification of the polymerase’s C-terminal domain that marks the elongation phase of transcription, when RNA synthesis is actively proceeding along the gene body. The co-localization of the histone mark with these polymerase states suggested that H3K4me3 under hypoxia was not just a passive correlate of activity but was functionally entwined with both the initiation and the elongation of zygotic transcripts.

Direct measurements supported that interpretation. Global levels of RNA polymerase II and of its Ser2-phosphorylated form were both increased under hypoxia, and the polymerase was recruited to the very regions that had gained H3K4me3, initiating transcription and driving elongation there. Immunofluorescence imaging of 5-EU incorporation, which labels newly synthesized RNA, showed that transcriptional activity in hypoxia-cultured embryos matched that of in vivo embryos at the late 2-cell stage, reinforcing the physiological fidelity of the hypoxic culture condition. At key ZGA loci including Obox3, Klf17, Ep300 and L3mbtl2, the team observed the H3K4me3 and polymerase signals converging on the genes that define the embryonic program.

Perhaps the most compelling piece of evidence came from a pharmacological experiment. The researchers treated embryos with CPI-455, an inhibitor of the lysine demethylases that normally erase H3K4me3. Blocking demethylation raised H3K4me3 levels, and, crucially, Pol II and Ser2P signals increased as a result. That causality test ties the epigenetic mark to the transcriptional machinery in a directional way: when H3K4me3 is preserved, the polymerase arrives in greater numbers and proceeds more vigorously into elongation. It also implicates enzymes such as KDM5B, a lysine demethylase targeted by this class of inhibitors, as potential regulators of the ZGA landscape that hypoxia appears to counterbalance.

Not every consequence of hypoxia pointed toward activation. Consistent with the reduced H3K4me3 at repetitive elements, the team found lower LINE1 transcription in hypoxia-cultured embryos, while ERV1 and ERVK retrotransposon transcripts were significantly upregulated under normoxia in keeping with their elevated H3K4me3 marks; LINE2, ERVL, B2 and B4 elements showed no significant differences. This pattern suggests that hypoxia helps the embryo silence potentially destabilizing repeat transcription while sharpening the activation of genuine zygotic genes, a double benefit at a developmental stage when genome integrity and precise timing are both at a premium.

The broader significance of the study lies in the bridge it builds between clinical practice and basic developmental biology. Low-oxygen culture has been a mainstay of assisted reproduction largely on empirical grounds, adopted because embryos simply did better. With this work, the field gains a molecular rationale: hypoxia raises promoter H3K4me3, promotes chromatin accessibility, and orchestrates acute zygotic transcription by fueling both polymerase recruitment and productive elongation. The authors frame their findings as a theoretical foundation for optimizing ART protocols and improving clinical success rates. If the same H3K4me3-dependent mechanism operates in human embryos, it could inform how culture conditions are tuned, how embryo quality is assessed, and potentially how pharmacological agents that modulate histone methylation might be used to rescue embryos that would otherwise arrest. For now, the mouse data provide a vivid picture of an embryo’s first genetic awakening being tuned, quite literally, by the air it breathes, or rather by the carefully reduced oxygen that mimics the environment of the oviduct where early development naturally unfolds.

Subject of Research: Epigenetic regulation of zygotic genome activation under hypoxic embryo culture

Article Title: H3K4me3-dependent transcript elongation drives hypoxia-enhanced zygotic genome activation

Article References: Chen, B., Sun, X., Miao, Y., Sun, S., Deng, M., & Liu, H. (2026). H3K4me3-dependent transcript elongation drives hypoxia-enhanced zygotic genome activation. BMC Biology. https://doi.org/10.1186/s12915-026-02762-w

Image Credits: AI Generated

DOI: 10.1186/s12915-026-02762-w

Keywords: zygotic genome activation, hypoxia, H3K4me3, RNA polymerase II, transcript elongation, embryo culture, assisted reproductive technologies, chromatin, epigenetics, mouse embryo, BMC Biology, fertility

The story begins nearly a century ago. In the 1920s, the Russian biologist Alexander Gurwitsch performed an experiment that remains one of the strangest in biology: he showed that light emitted from the tip of one onion root could stimulate cell division in a second root placed nearby, even when all known chemical signals were excluded. Gurwitsch called this “mitogenetic radiation” and introduced the idea of a biological “field” of forces governing cellular behavior. By the 1930s he had discovered that atmospheric oxygen was required for the effect, hinting that the radiation arose from reactions involving short-lived free radicals—species whose chemistry was only beginning to be understood.

Modern biophysics has largely vindicated the physical basis of those early observations. When single electrons leak from the mitochondrial electron transport chain onto molecular oxygen, they form superoxide anions, which are converted to hydrogen peroxide and, ultimately, to singlet oxygen—an electronically excited state of O2. Singlet oxygen emits photons at roughly 780 nanometers, and its dimers produce characteristic bands near 585, 635, and 703 nanometers. Excited carbonyl compounds generated during the peroxidation of mitochondrial membrane lipids add emissions in the 500 to 560 nanometer range, while some radical recombination reactions release enough energy to produce ultraviolet photons between 230 and 300 nanometers. In other words, the entire spectrum from ultraviolet to infrared can be traced back to superoxide formation and lipid peroxidation, with early studies attributing up to 75 percent of visible emission to free radical recombination.

What has changed in recent years is the recognition that this photon production is not a steady drip but a pulsatile, coordinated phenomenon. Beginning in the early 2000s, researchers using targeted fluorescent probes discovered “mitochondrial superoxide flashes”—transient bursts of superoxide generation within the mitochondrial matrix lasting roughly 10 to 15 seconds. Subsequent imaging showed that calcium uptake, membrane potential, and pH all fluctuate in synchrony during individual flashes, indicating that each event reflects a coordinated, transient reorganization of mitochondrial physiology. In skeletal muscle and cardiac tissue, these flashes often occur simultaneously among spatially clustered mitochondria. The prevailing picture has therefore shifted from mitochondria as isolated, passive producers of ATP and reactive oxygen species to mitochondria as components of an interconnected network whose output is regulated through amplitude and frequency modulation—much like AM and FM radio signals.

Here the arithmetic becomes striking. A photomultiplier tube placed above a liver cell culture containing about six million cells typically records no more than a few hundred photons per second per square centimeter—roughly one detected photon per second per 2,000 cells. But estimates based on cellular oxygen consumption tell a very different story. An average rat cell processes on the order of 10^12 oxygen molecules per day, and if about 2 percent undergo single-electron reduction to superoxide, with at least 1 percent of those reactions contributing to photon production, each cell generates roughly 2,300 photons per second. The discrepancy between calculated production and detected emission implies that intracellular absorption of mitochondrially produced light must be extraordinarily high—on the order of a millionfold or greater. The question then becomes: what inside the cell is soaking up all this light?

The authors argue that the prime candidate is the nucleus, and specifically chromatin—the complex of DNA and associated proteins. The nucleus occupies about 10 percent of cell volume and is surrounded by thousands of mitochondria in the perinuclear cytoplasm, so synchronously emitted photon pulses are likely to impinge upon it with high probability. Supporting evidence comes from decades of delayed luminescence experiments, in which cells are exposed to external light and then monitored in complete darkness as they re-emit stored photons. Cell fractionation studies showed that the cytoplasm, including mitochondria and ribosomes, exhibits little long-term photon storage, while intact isolated nuclei retain even more capacity than whole cells. Crucially, when DNA was separated from its associated proteins, neither fraction alone retained significant luminescence—photon storage is an emergent property of chromatin as an integrated structure, not of naked DNA.

Even more intriguing, photon storage capacity varies systematically with cellular differentiation. In classic experiments spanning 17 mammalian cell lines, poorly differentiated tumor cells emitted photons rapidly and intensely, indicating minimal storage, while normal, well-differentiated cells showed slow, prolonged emission consistent with high storage capacity. Well-differentiated hepatoma cells fell in between. Normal liver cells even retained more photons at higher culture densities, consistent with reabsorbing light emitted by their neighbors, whereas poorly differentiated tumor cells continued to pour out photons regardless of density. Whether this optical signature reflects cause or consequence of the differentiated state remains open, but the correlation is consistent across tissues and species.

The paper then confronts a fundamental question that chromatin biology has largely left unanswered: what physical principle drives chromatin motion at the molecular level? Contemporary models depict the genome as a dynamic, fluid mosaic—compacted a thousandfold yet constantly remodeled by ATP-dependent complexes, transcription bubbles traveling along genes, and topoisomerases resolving topological stress. The authors propose that light provides a key part of the answer through excitonic processes: delocalized electron–hole excitations that can propagate along the regular hydrogen-bonded geometry of protein alpha-helices and through stacked DNA bases, persisting for up to milliseconds before relaxing with red-shifted photon emission. Recent ultrafast spectroscopy has shown that exciton lifetimes in DNA depend on base sequence, with guanine-rich tracts localizing charge and adenine-rich tracts facilitating migration. Charge delocalization within chromatin could transiently alter local conformation and electrostatic potential, potentially modulating the affinity of regulatory proteins for DNA.

Putting all the pieces together, the authors advance a speculative but testable model: two alternating, pulsatile photonic spectra—one originating from mitochondrial emission, the other from delayed chromatin–DNA luminescence—together sustain a dynamic equilibrium between mitochondrial energy production and the energy demands of chromatin organization and gene regulation. Mitochondrial light would act as a primary trigger exciting chromatin, while chromatin’s red-shifted delayed emission would feed back onto the mitochondrial network, tuning respiration to the genome’s activity. Notably, the action spectrum of low-intensity light therapy, which stimulates cytochrome c oxidase and ATP synthesis, does not match the primary emission bands of mitochondrial reactive oxygen species—but it could match red-shifted, delayed luminescence from chromatin, offering a possible resolution of the long-standing paradox by which light therapy transiently increases reactive oxygen species yet protects tissue from oxidative damage.

The authors are careful to frame this as a hypothesis in need of experimental verification, and they outline a concrete research program: characterizing spontaneous emission spectra under physiological and stress conditions using high-sensitivity multi-band filter systems, using the 5-to-10-second rhythm of mitochondrial pulsations to deposit light energy into chromatin with narrowly defined wavelengths, and recording wavelength-specific delayed emission with modern time-resolved photomultiplier equipment. Recent work showing that red and near-infrared light treatment alters biophoton emission in stressed but not healthy cell cultures offers an early encouraging sign. If the model survives such scrutiny, biophotons would graduate from metabolic noise to a genuine regulatory layer—one in which the cell’s inner light helps choreograph the dance of its own genome.

Subject of Research: The proposed regulatory role of ultra-weak photon emission in mitochondrial–chromatin cross-talk and cellular energy metabolism

Article Title: A cellular (bio) photon field in mitochondrial-chromatin cross-talk: a hypothesis

Article References: Van Wijk, R., & Van Wijk, E. P. A. (2026). A cellular (bio) photon field in mitochondrial-chromatin cross-talk: a hypothesis. Frontiers in Photobiology, 4, Article 1872069. https://doi.org/10.3389/fphbi.2026.1872069

Image Credits: AI Generated

DOI: 10.3389/fphbi.2026.1872069

Keywords: biophotons, ultra-weak photon emission, mitochondria, chromatin, reactive oxygen species, low-intensity light therapy, photobiomodulation, delayed luminescence, excitons, cytochrome c oxidase, gene regulation, cell metabolism

The original research had proposed an elegant biological framework. Multiple myeloma is a cancer of plasma cells, the antibody-producing cells of the immune system, and its treatment typically involves DNA-damaging agents such as alkylating drugs. The authors argued that the way DNA is packaged into chromatin, the tightly coiled complex of DNA and proteins inside the nucleus, determines how efficiently a myeloma cell can repair the damage inflicted by chemotherapy. Cells with open, transcriptionally active chromatin were suggested to repair DNA differently from cells with condensed, silent chromatin, and this difference was proposed to influence clinical outcomes.

That hypothesis was scientifically compelling because it connected three levels of biology into a single predictive model. At the molecular level, chromatin structure controls access of repair enzymes to damaged DNA. At the cellular level, repair efficiency determines whether a cancer cell survives treatment. At the clinical level, survival and relapse patterns reflect those cellular decisions aggregated across millions of tumor cells. A validated version of this model could have guided oncologists in selecting therapies based on the epigenetic state of a patient’s myeloma cells, potentially transforming treatment planning for a disease that remains incurable despite decades of therapeutic advances.

The retraction, however, was triggered not by a failure of the underlying biology but by irregularities in the published figures. The Editor-in-Chief of the British Journal of Cancer identified several image problems that undermined confidence in the paper’s data. Figure 1A and Figure 1B appeared to partially overlap, suggesting that panels intended to show different experimental conditions may have contained duplicated content. Multiple partial overlaps were also detected among Figures 1E through 1K, a pattern that image-integrity specialists interpret as evidence that the same underlying data may have been reused across panels presenting distinct results.

More troubling still were the cross-publication overlaps. Figure 1F through 1H in the retracted article appeared to partially overlap with Figure 3F through 3H in a separate 2016 paper published in the journal Blood, which examined DNA repair in myeloma plasma cells and the effect of the nonhomologous end-joining inhibitor SCR7. When identical or nearly identical images appear in different papers describing different experiments, the concern extends beyond a single study and raises questions about the reliability of an entire body of work. Additional overlaps were found within Figure 3C of the retracted article itself, where panels labeled for different p53-related experimental conditions, including designations referred to as S15-p53 with high variability, normal response, and resistant categories, appeared to share partially duplicated content.

The investigation faced a fundamental obstacle that will resonate with anyone following the reproducibility crisis in science. Because of the age of the article, the original data were no longer available. Without the underlying raw files, the authors had no way to demonstrate that the overlapping images resulted from innocent formatting errors rather than from manipulation or data reuse. The authors could not provide a satisfactory response to the several concerns raised, and the Editor-in-Chief therefore concluded that confidence in the reliability of the reported data could no longer be maintained.

The authors’ responses during the investigation varied in a way that itself carries scientific weight. S. A. Kyrtopoulos, M. A. Dimopoulos, and V. L. Souliotis did not respond to correspondence from the publisher about the editorial expression of concern. The publisher was unable to contact M. Gkotzamanidou, P. P. Sfikakis, and C. Bamia at all. This pattern of non-response and unreachable authors has become a familiar feature of retraction cases, and it highlights a structural weakness in the self-correction machinery of science: journals can withdraw a paper, but they cannot compel authors to engage with the process or explain what happened to their data.

The retraction also implicates a linked study, since the 2016 Blood paper on DNA repair in myeloma plasma cells and the SCR7 inhibitor is cited in the retraction note as the source of one set of overlapping figures. That paper had reported that DNA repair capacity in myeloma plasma cells correlates with clinical outcome and that pharmacological inhibition of nonhomologous end-joining, one of the two major pathways cells use to repair DNA double-strand breaks, could affect treatment results. SCR7 works by interfering with DNA ligase IV, an enzyme essential for sealing the breaks created by the nonhomologous end-joining machinery, thereby pushing cells toward less faithful repair routes and theoretically increasing chemotherapy sensitivity. Whether that paper will face its own editorial action remains to be seen, but the shared image irregularities mean its findings must now be interpreted with caution.

For the myeloma research community, the loss of this paper removes a piece of a larger puzzle rather than demolishing the puzzle itself. The idea that chromatin architecture and transcriptional state modulate DNA repair outcomes remains an active and well-supported area of investigation in many cancer types. Genome-wide mapping technologies, single-cell epigenetic profiling, and CRISPR-based perturbation experiments have since provided far more rigorous tools for testing how chromatin accessibility shapes repair pathway choice at DNA breaks. The retracted study’s central question, why identical chemotherapy regimens produce wildly different outcomes in different patients, remains one of the most important unsolved problems in hematologic oncology.

The case also serves as a vivid reminder of how modern science polices itself. Automated image-forensics tools and diligent readers now routinely detect duplicated panels that escaped peer review years earlier, and journals increasingly act on concerns even when the original data have vanished. The retraction note ends without vindication or explanation, only the stark editorial conclusion that the Editor-in-Chief no longer has confidence in the reliability of the data reported. For patients and researchers alike, the episode underscores that scientific progress depends not only on bold hypotheses about chromatin, transcription, and DNA repair, but on the integrity of every image, every dataset, and every claim that carries those hypotheses into the medical literature.

Subject of Research: retraction

Article Title: Retraction Note: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma

Article References: Gkotzamanidou, M., Sfikakis, P. P., Kyrtopoulos, S. A., Bamia, C., Dimopoulos, M. A., & Souliotis, V. L. (2026). Retraction Note: Chromatin structure, transcriptional activity and DNA repair efficiency affect the outcome of chemotherapy in multiple myeloma. British Journal of Cancer. https://doi.org/10.1038/s41416-026-03646-0

Image Credits: AI Generated

DOI: 10.1038/s41416-026-03646-0

Keywords: retraction, multiple myeloma, DNA repair, chromatin, research integrity, British Journal of Cancer, chemotherapy, Note, structure, transcriptional, activity, repair

The work, published in the journal Molecular Cell, was led by researchers at the Centre for Genomic Regulation (CRG) in Barcelona together with the City University of Hong Kong and the Guangdong Provincial People’s Hospital of the Guangdong Academy of Medical Sciences at Southern Medical University. The team describes a new class of fluorescent probes, called HoTs, which are small enough to slip into living cells unaided and bind directly to DNA. What makes them special is their blinking behaviour: rather than glowing continuously, they flicker intermittently, like strings of fairy lights switching on and off at random.

That flickering is not a quirk but the key to the entire technique. Conventional light microscopes hit a hard physical limit at roughly 200 nanometres, the diffraction barrier that blurs anything packed more tightly than that. If every dye molecule in a sample lit up simultaneously, even the most advanced microscope would simply record an overlapping glow. But if molecules emit one at a time, or in small sparse groups, each flash can be localised individually. Thousands of snapshots, each capturing a scattered subset of blinking probes, can then be stitched together by software into a reconstructed image far sharper than any single exposure. This is the principle behind single-molecule localisation microscopy, and the new probes were engineered specifically to deliver the right blinking dynamics for it.

With the HoT dyes, the researchers deployed STORM, a stochastic optical reconstruction microscopy technique, to visualise DNA inside living human cells at a resolution of 20 nanometres. That is a tenfold improvement over the conventional limit, achieved not on fixed and chemically treated samples but on cells that were alive throughout the imaging. The team demonstrated the approach in living human skin cells and in living HeLa cancer cells grown in the laboratory. In parallel, they pushed the technology even further on preserved cells, using MINFLUX, an ultra-high-resolution method that tracks individual fluorophores, to pinpoint single dye molecules to within three nanometres. The diameter of the DNA double helix is approximately two nanometres, so a localisation precision of three nanometres brings imaging to the very doorstep of the molecule itself.

The significance of that achievement becomes clear when one considers what biologists have been missing. Every human cell contains roughly two metres of DNA, folded and compressed into a nucleus only a few micrometres across. The degree to which that DNA is wound tightly or left loose is not decorative; it is one of the principal layers of biological control. Tightly packed DNA tends to be silent, while loosely packed regions are accessible to the molecular machinery that reads genes. Yet almost all existing images of DNA folding come from dead, fixed cells, because the powerful microscopy techniques needed to track individual genomic components typically require harsh chemicals and intense laser illumination that living cells cannot survive. The new probes sidestep that constraint, allowing chromatin, the natural state of DNA in cells, to be watched in motion.

Professor Hongyan Sun of the City University of Hong Kong, co-senior author of the study, highlighted the central design problem: the key challenge was to create fluorophores with the right blinking behaviour for super-resolution imaging. ICREA Research Professor Pia Cosma of the CRG, senior author, explained the dual power of the system: with the same dye, researchers can watch DNA moving in a living cell, revealing how chromatin behaves, and zoom into preserved cells until they are almost at the scale of the DNA molecule itself. Combining both approaches, she noted, allows one of the main layers of control in human biology to be seen at unprecedented resolution.

The team did not stop at laboratory cell lines. In a striking demonstration of clinical relevance, they applied the probes to ordinary wax-preserved tissue slices taken from three bowel cancer patients, the same kind of samples hospitals routinely store after biopsies. In the tumour tissue, the DNA was noticeably looser and more spread out than in the healthy tissue sitting immediately beside it. This observation aligns with earlier findings that DNA unpacks progressively as cancer takes hold, and it suggests a provocative possibility: how loosely a cell’s DNA is folded could eventually serve as a measurable indicator of how far a tumour has progressed or how aggressive it is. Today, doctors examine these biopsies largely by eye using staining methods more than a century old. The ability to add a three-dimensional readout of how DNA occupies space inside cells could one day become an additional diagnostic clue.

The probes also proved useful beyond human tissue. The researchers imaged slices of zebrafish eye, an animal famous for its ability to regrow damaged retina. Retinal regeneration in these fish is thought to involve cells loosening their DNA packaging in order to become flexible again, and the new dyes offer a way to observe that process directly at nanometre scale. Such experiments hint at a broader future for the technology in regenerative medicine, where identifying which cells have entered a plastic, stem-like state is a central challenge.

Artificial intelligence enters the story as a force multiplier. The same team had previously unveiled a program called AINU, short for AI of the Nucleus, in 2024, which scans super-resolution images of cellular DNA and detects patterns far too subtle for the human eye. Originally, AINU could only analyse cells that had been killed and preserved. Trained on the new living-cell images produced with the HoT probes, the AI correctly distinguished skin cells from stem cells between 96 and 98 per cent of the time. The two cell types carry identical genomes but fold their DNA differently, and the algorithm could see that difference in living material. The researchers hope the same principle could eventually be turned to distinguishing cancerous from healthy tissue, or to selecting the most promising stem cells to accelerate regenerative medicine.

The technology is not without limits, and the authors are candid about them. The probes coat the entirety of the DNA rather than highlighting any single gene, so they reveal global packaging architecture rather than gene-specific organisation. The very sharpest pictures, at the three-nanometre scale, required preserved rather than living cells, although the team reports that follow-up studies are already under way and that MINFLUX has the potential to image the probes in living cells as well. Even so, the combination demonstrated here, live-cell chromatin dynamics at 20 nanometres and near-helix-scale localisation in preserved clinical samples, marks a genuine step change. A staining method from the nineteenth century may soon share the microscope bench with blinking molecular probes and AI readers, giving clinicians and researchers a view of the genome not as a static blueprint but as a living, breathing three-dimensional structure whose shape itself carries diagnostic information.

Subject of Research: Super-resolution fluorescence imaging of DNA packaging in living and preserved cells using self-blinking probes

Article Title: Self-blinking ‘fairy lights’ allow DNA to be imaged at almost double helix width resolution

Article References: Self-blinking ‘fairy lights’ allow DNA to be imaged at almost double helix width resolution. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: super-resolution microscopy, STORM, MINFLUX, chromatin, DNA packaging, fluorescent probes, cancer diagnostics, biopsy imaging, artificial intelligence, stem cells, zebrafish, Molecular Cell